43 /100
MEDIUM RISK
Score updated Apr 13, 2026

BBOT

BridgeBio Oncology Therapeutics, Inc. — Stock Dilution Tracker

Track BBOT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track BBOT — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BBOT.
🔔 Track BBOT — Get forecast alerts →
💹 Market Data
Market Cap$672.28M
Shares Outstanding80.03M
Float31.16M
Cash$425.46M
Debt$2.77M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 5.6% shares (2025Q4 vs prior)
54 institutional holders · 60.00M shares
#1 Cormorant Asset Management, LP 17.88M shares
#2 DEERFIELD MANAGEMENT COMPANY, L.P. 4.89M shares
#3 Omega Fund Management, LLC 3.29M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.39M
Days to Cover18.9
% of Float7.7%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Mar 12, 2026
4 INSIDER TRANSACTION Mar 12, 2026
4 INSIDER TRANSACTION Mar 12, 2026
424B3 ATM Mar 06, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track BBOT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BBOT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required